Improving Depression Screening in Adult Patients With Cancer

Overview

Journal J Adv Pract Oncol

Date 2025 Jan 13

PMID 39802531

Authors

Madison L Krekel

Dorothie Durosier Mertilus

Affiliations

Soon will be listed here.

Abstract

Depression in adult patients with cancer may lead to decreased treatment adherence, decreased quality of life, and possible suicidal ideation. Adequate screening can promote timely diagnosis and treatment of depression. A quality improvement project was implemented at a cancer center in which adult patients are diagnosed with and treated for cancer. A paper version of the 9-item Patient Health Questionnaire (PHQ-9), a validated tool to screen for depression, was provided to patients during their scheduled appointment. A two-sample test of proportions was used to compare the proportion of patients screened before project implementation to the proportion of patients screened after project implementation. Depression screening rates increased from 2% before to 12% after project implementation. Frequent screening with the PHQ-9 should occur in adult patients with cancer to adequately identify depressive symptoms. Adequate screening will provide the necessary information for providers to make referrals to mental health services and allow patients to adhere to their treatment plans, improving their quality of life.

References

Degefa M, Dubale B, Bayouh F, Ayele B, Zewde Y . Validation of the PHQ-9 depression scale in Ethiopian cancer patients attending the oncology clinic at Tikur Anbessa specialized hospital. BMC Psychiatry. 2020; 20(1):446. PMC: 7488004. DOI: 10.1186/s12888-020-02850-3. View

Pilevarzadeh M, Amirshahi M, Afsargharehbagh R, Rafiemanesh H, Hashemi S, Balouchi A . Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis. Breast Cancer Res Treat. 2019; 176(3):519-533. DOI: 10.1007/s10549-019-05271-3. View

Mitchell A . Screening for cancer-related distress: when is implementation successful and when is it unsuccessful?. Acta Oncol. 2013; 52(2):216-24. DOI: 10.3109/0284186X.2012.745949. View

Ganz P, Bower J, Partridge A, Wolff A, Thorner E, Joffe H . Screening for Depression in Younger Breast Cancer Survivors: Outcomes From Use of the 9-item Patient Health Questionnaire. JNCI Cancer Spectr. 2021; 5(3). PMC: 8216636. DOI: 10.1093/jncics/pkab017. View

Bortolato B, Hyphantis T, Valpione S, Perini G, Maes M, Morris G . Depression in cancer: The many biobehavioral pathways driving tumor progression. Cancer Treat Rev. 2016; 52:58-70. DOI: 10.1016/j.ctrv.2016.11.004. View

Levis B, Sun Y, He C, Wu Y, Krishnan A, Bhandari P . Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis. JAMA. 2020; 323(22):2290-2300. PMC: 7284301. DOI: 10.1001/jama.2020.6504. View

Mansour M, Krishnaprasadh D, Lichtenberger J, Teitelbaum J . Implementing the Patient Health Questionnaire Modified for Adolescents to improve screening for depression among adolescents in a Federally Qualified Health Centre. BMJ Open Qual. 2020; 9(4). PMC: 7542616. DOI: 10.1136/bmjoq-2019-000751. View

Gorman D, Ham S, Staab E, Vinci L, Laiteerapong N . Medical Assistant Protocol Improves Disparities in Depression Screening Rates. Am J Prev Med. 2021; 61(5):692-700. PMC: 8627913. DOI: 10.1016/j.amepre.2021.05.010. View

Rancans E, Trapencieris M, Ivanovs R, Vrublevska J . Validity of the PHQ-9 and PHQ-2 to screen for depression in nationwide primary care population in Latvia. Ann Gen Psychiatry. 2018; 17:33. PMC: 6071402. DOI: 10.1186/s12991-018-0203-5. View

10.

Kroenke K, Spitzer R, Williams J . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606-13. PMC: 1495268. DOI: 10.1046/j.1525-1497.2001.016009606.x. View

11.

Kroenke K, Spitzer R, Williams J . The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003; 41(11):1284-92. DOI: 10.1097/01.MLR.0000093487.78664.3C. View

12.

Negeri Z, Levis B, Sun Y, He C, Krishnan A, Wu Y . Accuracy of the Patient Health Questionnaire-9 for screening to detect major depression: updated systematic review and individual participant data meta-analysis. BMJ. 2021; 375:n2183. PMC: 8491108. DOI: 10.1136/bmj.n2183. View

13.

Decker V, Tofthagen C . Depression: Screening, Assessment, and Interventions in Oncology Nursing. Clin J Oncol Nurs. 2021; 25(4):413-421. DOI: 10.1188/21.CJON.413-421. View

14.

Mulvihill E, Furru R, Goldstein-Leever A, Driest K, Lemle S, MacDonald D . Targeted provider education and pre-visit planning increase rates of formal depression screening in childhood-onset SLE. Pediatr Rheumatol Online J. 2021; 19(1):116. PMC: 8330037. DOI: 10.1186/s12969-021-00576-4. View

15.

Levis B, Benedetti A, Thombs B . Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019; 365:l1476. PMC: 6454318. DOI: 10.1136/bmj.l1476. View

16.

Hahn E, Munoz-Plaza C, Pounds D, Lyons L, Lee J, Shen E . Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial. JAMA. 2022; 327(1):41-49. PMC: 8728610. DOI: 10.1001/jama.2021.22596. View

17.

Lysandrou M, Quaye N, Landes K, Crawford R, Desai P, Creary S . Evaluating self- vs interviewer-administered screening for depression in sickle cell disease. Blood Adv. 2023; 8(3):699-702. PMC: 10844810. DOI: 10.1182/bloodadvances.2023012083. View

18.

Arrieta J, Aguerrebere M, Raviola G, Flores H, Elliott P, Espinosa A . Validity and Utility of the Patient Health Questionnaire (PHQ)-2 and PHQ-9 for Screening and Diagnosis of Depression in Rural Chiapas, Mexico: A Cross-Sectional Study. J Clin Psychol. 2017; 73(9):1076-1090. PMC: 5573982. DOI: 10.1002/jclp.22390. View

19.

Dajpratham P, Pukrittayakamee P, Atsariyasing W, Wannarit K, Boonhong J, Pongpirul K . The validity and reliability of the PHQ-9 in screening for post-stroke depression. BMC Psychiatry. 2020; 20(1):291. PMC: 7285729. DOI: 10.1186/s12888-020-02699-6. View